Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Hepper, N. G., Black, L. F., Gleich, G. J. & Kueppers, F. The prevalence of alpha 1-antitrypsin deficiency in selected groups of patients with chronic obstructive lung disease. Mayo Clin Proc 44, 697–710 (1969).
2. Ogushi, F., Fells, G. A., Hubbard, R. C., Straus, S. D. & Crystal, R. G. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 80, 1366–1374, https://doi.org/10.1172/JCI113214 (1987).
3. Stocks, J. M. et al. Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira. COPD 3, 17–23 (2006).
4. Hunt, J. M. & Tuder, R. Alpha 1 anti-trypsin: one protein, many functions. Current molecular medicine 12, 827–835 (2012).
5. Bergin, D. A., Hurley, K., McElvaney, N. G. & Reeves, E. P. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz) 60, 81–97, https://doi.org/10.1007/s00005-012-0162-5 (2012).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献